A paradigm shift in bioavailability enhancement using solid self emulisifying drug delivery system

Background: Solids are physically and chemically more stable compared to liquid formulations. The Solid SEDDS form is preferred over the liquid SEDDS form to enhance the oral bioavailability of lipophilic medications. Solid SEDDS are isotropic mixtures of oil, surfactant, and co-solvent. Methodology...

Full description

Saved in:
Bibliographic Details
Main Authors: Sankararajan Umadevi, Rajathi Senthil Boopathi, Ezhilarasan
Format: Article
Language:English
Published: Creative Pharma Assent 2025-02-01
Series:Journal of Applied Pharmaceutical Research
Subjects:
Online Access:https://japtronline.com/index.php/joapr/article/view/704
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850043377061462016
author Sankararajan Umadevi
Rajathi Senthil Boopathi
Ezhilarasan
author_facet Sankararajan Umadevi
Rajathi Senthil Boopathi
Ezhilarasan
author_sort Sankararajan Umadevi
collection DOAJ
description Background: Solids are physically and chemically more stable compared to liquid formulations. The Solid SEDDS form is preferred over the liquid SEDDS form to enhance the oral bioavailability of lipophilic medications. Solid SEDDS are isotropic mixtures of oil, surfactant, and co-solvent. Methodology: A liquid-solid compact approach is followed to convert liquid SEDDS into solid SEDDS. Melt granulation, melt extrusion, spray drying, adsorption to solid carriers, and freeze drying are some approaches to converting liquid SEDDS into solid SEDDS. Various solid self-emulsifying materials in several solid dosage forms, like solid dispersions, tablets, capsules, and powders. Result and discussion: Solid SEDDS results in solubility studies, particle size and polydispersity index (PDI), zeta potential, in vitro drug release, solid-state characterization (e.g., XRD, DSC), and stability studies. In summary, S-SEDDS seems to be a viable strategy for improving the distribution of poorly water-soluble drugs through enhanced bioavailability, stability, and administration simplicity. Conclusion: In this review, the research will be extended to the different approaches toward improving the bioavailability, stability, and solubility of poorly soluble drugs into solid SEDDS. All these components are intended to act as primary instructions for future development in SSEDDS.
format Article
id doaj-art-3d34eae0dc884500aeb18faf99d7a44c
institution DOAJ
issn 2348-0335
language English
publishDate 2025-02-01
publisher Creative Pharma Assent
record_format Article
series Journal of Applied Pharmaceutical Research
spelling doaj-art-3d34eae0dc884500aeb18faf99d7a44c2025-08-20T02:55:16ZengCreative Pharma AssentJournal of Applied Pharmaceutical Research2348-03352025-02-01131142410.69857/joapr.v13i1.704705A paradigm shift in bioavailability enhancement using solid self emulisifying drug delivery systemSankararajan Umadevi0Rajathi Senthil Boopathi1Ezhilarasan2School of Pharmaceutical Sciences, Vels Institute of Science, Technology and Advanced Studies (VISTAS), Pallavaram, Chennai, Tamilnadu, IndiaSchool of Pharmaceutical Sciences, Vels Institute of Science, Technology and Advanced Studies (VISTAS), Pallavaram, Chennai, Tamilnadu, IndiaSchool of Pharmaceutical Sciences, Vels Institute of Science, Technology and Advanced Studies (VISTAS), Pallavaram, Chennai, Tamilnadu, IndiaBackground: Solids are physically and chemically more stable compared to liquid formulations. The Solid SEDDS form is preferred over the liquid SEDDS form to enhance the oral bioavailability of lipophilic medications. Solid SEDDS are isotropic mixtures of oil, surfactant, and co-solvent. Methodology: A liquid-solid compact approach is followed to convert liquid SEDDS into solid SEDDS. Melt granulation, melt extrusion, spray drying, adsorption to solid carriers, and freeze drying are some approaches to converting liquid SEDDS into solid SEDDS. Various solid self-emulsifying materials in several solid dosage forms, like solid dispersions, tablets, capsules, and powders. Result and discussion: Solid SEDDS results in solubility studies, particle size and polydispersity index (PDI), zeta potential, in vitro drug release, solid-state characterization (e.g., XRD, DSC), and stability studies. In summary, S-SEDDS seems to be a viable strategy for improving the distribution of poorly water-soluble drugs through enhanced bioavailability, stability, and administration simplicity. Conclusion: In this review, the research will be extended to the different approaches toward improving the bioavailability, stability, and solubility of poorly soluble drugs into solid SEDDS. All these components are intended to act as primary instructions for future development in SSEDDS.https://japtronline.com/index.php/joapr/article/view/704solid seddssolubilitystabilityliquid emulsificationpoorly solubledosage form
spellingShingle Sankararajan Umadevi
Rajathi Senthil Boopathi
Ezhilarasan
A paradigm shift in bioavailability enhancement using solid self emulisifying drug delivery system
Journal of Applied Pharmaceutical Research
solid sedds
solubility
stability
liquid emulsification
poorly soluble
dosage form
title A paradigm shift in bioavailability enhancement using solid self emulisifying drug delivery system
title_full A paradigm shift in bioavailability enhancement using solid self emulisifying drug delivery system
title_fullStr A paradigm shift in bioavailability enhancement using solid self emulisifying drug delivery system
title_full_unstemmed A paradigm shift in bioavailability enhancement using solid self emulisifying drug delivery system
title_short A paradigm shift in bioavailability enhancement using solid self emulisifying drug delivery system
title_sort paradigm shift in bioavailability enhancement using solid self emulisifying drug delivery system
topic solid sedds
solubility
stability
liquid emulsification
poorly soluble
dosage form
url https://japtronline.com/index.php/joapr/article/view/704
work_keys_str_mv AT sankararajanumadevi aparadigmshiftinbioavailabilityenhancementusingsolidselfemulisifyingdrugdeliverysystem
AT rajathisenthilboopathi aparadigmshiftinbioavailabilityenhancementusingsolidselfemulisifyingdrugdeliverysystem
AT ezhilarasan aparadigmshiftinbioavailabilityenhancementusingsolidselfemulisifyingdrugdeliverysystem
AT sankararajanumadevi paradigmshiftinbioavailabilityenhancementusingsolidselfemulisifyingdrugdeliverysystem
AT rajathisenthilboopathi paradigmshiftinbioavailabilityenhancementusingsolidselfemulisifyingdrugdeliverysystem
AT ezhilarasan paradigmshiftinbioavailabilityenhancementusingsolidselfemulisifyingdrugdeliverysystem